CDC on infectious diseases in the United States: 1900-99

Population and Development Review

Volumn 25, Issue 3, 1999, Pages 635-640

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745036188     PISSN: 00987921     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1728-4457.1999.00635.x     Document Type: Article

References (21)

1. Department of Commerce and Labor, Bureau of the Census. Mortality Statistics. 1900 to 1904. Washington, DC: US Department of Commerce and Labor, 1906.
2. Hoyert DL, Kochanek KD, Murphy SL. Deaths: final data for 1997. Hyattsville, Maryland: US Department of Health and Human Services, Public Health Service, CDC, National Center for Health Statistics, 1999. (National vital statistics reports, vol 47, no. 19).
3. Crosby AW Jr. Epidemic and peace, 1918. Wesiport. Connecticut: Greenwood Press, 1976:311.
4. United Nations Program on HIV/AIDS and World Health Organization. AIDS epidemic update:
5. December 1998. Geneva, Switzerland: World Health Organization, 1999. Available at http://www.unaids. org/ highband/document/epidemio/wadr98e.pdf.
6. Lederberg J, Shope RE, Oaks SC Jr, eds. Microbial threats to health in the United States. Washington, DC: National Academy Press, 1992.
7. Hinman A. 1889 to 1989: a century of health and disease. Public Health Rep 1990;105:374-80.
8. National Office of Vital Statistics. Vital statistics - special repons, death rates by age, race, and sex. United States, 1900-1953: tuberculosis, all forms; vol 43, no. 2. Washington, DC: US Department of Health, Education, and Welfare, 1956.
9. CDC. Status report on the Childhood Immunization Initiative: reported cases of selected vaccinepreventable diseases - United States, 1996. MMWR 1997;46:665-71.
10. Morrow PA. Report of the committee of seven of the Medical Society of the County of New York on the prophylaxis of venereal disease in New York City. N York M J 1901;74:1146.
11. Institute of Medicine. Emerging infections: microbial threats to health in the United States. Washington, DC: National Academy Press, 1994:vi.
12. Plikaytis BB, Marden JL, Crawford JT, Woodley CL, Butler WR, Shinnick TM. Multiplex PCR assay specific for the multidrug-resistant strain W of Mycobacterium tuberculosis. J Clin Microbiol 1994; 32:1542-6.
13. CDC. Reduced susceptibility of Staphyhcoccus aureus to vancomycin - Japan, 1996. MMWR 1997; 46:624-6.
14. CDC. Slaphylococcus aureus with reduced susceptibility to vancomycin - United States, 1997. MMWR 1997;46:765-6.
15. CDC. Update: Staphyloceccus aurcus with reduced susceptibility to vancomycin - United States, 1997. MMWR 1997;46:813-5.
16. Montesano R. Hainaut P, Wild CP. Hepatocellular carcinoma: from gene to public health. J Natl Cancer Inst 1997;89:1844-51.
17. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997;26(3 suppl 1):34S-38S.
18. Muñoz N, Bosch FX. The causal link between HPV and cervical cancer and its implications for prevention of cervical cancer. Bull Pan Am Health Organ 1996;30:362-77.
19. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet 1997;350:430-6.
20. Mattila KJ, Valtonen W, Nieminen MS, Asikainen S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin Infect Dis 1998;26:719-34.
21. CDC. Preventing emerging infectious diseases: a strategy for the 21st century. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1998.